Table 2

The 5-year cumulative risk of postoperative de novo epilepsy by indication for craniotomy among the subgroup of patients being alive without epilepsy at 1 year after craniotomy

Intracranial surgical diseaseTotal patientsPatients with epilepsyCR* at 5 years, % (95% CI)
All patients556259410.5 (9.7 to 11.4)
All tumours2749‡30111.0 (9.8 to 12.3)
 Astrocytoma1753318.3 (13.0 to 25.6)
 Cranial nerves306<5†0.4 (0.1 to 3.0)
 Embryonal801111.0 (5.7 to 21.3)
 Glioblastoma59210719.6 (16.5 to 23.4)
 Meningioma1022898.5 (6.8 to 10.6)
 Mesenchymal93<5†1.2 (0.2 to 8.5)
 Metastasis241176.5 (4.0 to 10.5)
 Oligodendroglioma1013234.8 (26.0 to 46.6)
All spontaneous haemorrhages172718510.2 (8.8 to 11.9)
 Cerebral aneurysm, ruptured532437.8 (5.8 to 10.6)
 Cerebral aneurysm, non-ruptured399133.3 (1.9 to 5.7)
 AVM or Moya-Moya disease1362013.2 (8.3 to 20.9)
 Intracerebral haemorrhage66010915.8 (13.0 to 19.1)
All traumatic haemorrhages828809.7 (7.8 to 12.1)
 Cerebral contusion1172420.9 (14.4 to 30.4)
 Epidural haemorrhage230135.1 (2.9 to 9.1)
 Traumatic subdural haemorrhage481439.1 (6.7 to 12.4)
Abscess1832712.2 (8.0 to 18.7)
Congenital malformations75<5†1.8 (0.3 to 12.8)
  • *Cumulative risks represent the risks of postoperative de novo epilepsy among patients alive with epilepsy and deceased patients with epilepsy.

  • †Not shown due to small numbers.

  • ‡No analyses done for the six small cancer groups (oligoastrocytoma, ependymal, pineal region, germ cell, sellar region and miscellaneous).

  • AVM, arteriovenous malformation of cerebral vessels; ICH, intracerebral haemorrhage.